Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Antoñanzas

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Gaceta Sanitaria|November 6, 2003
[Economic evaluation of pharmacotherapies for smoking cessation]F Antoñanzas, F Portillo
Gaceta Sanitaria|October 10, 2002
[Primary care: decentralization and efficiency]M Pinillos, F Antoñanzas
Revista Clinica Espanola|June 14, 2020
Assessment of the quality of antibiotics prescription in a regional health systemP Rojas García, F Antoñanzas Villar
Medicina Clinica|June 6, 1992
[A cost-effectiveness analysis of vaccination against the hepatitis B virus]F Antoñanzas, T Forcén, R Garuz
Revista Clinica Espanola|November 9, 2021
Assessment of the quality of antibiotics prescription in a regional health systemP Rojas García, F Antoñanzas Villar
Medicina Clinica|November 28, 1992
[Economic evaluation of prophylaxis with recombinant granulopoiesis stimulating factor]F Antoñanzas, J Rovira, R Garuz, et al.
Gaceta Sanitaria|December 3, 2002
[The cost of type 2 diabetes in Spain: the CODE-2 study]M Mata, F Antoñanzas, M Tafalla, et al.
Medicina Clinica|April 22, 1995
[The calculation of AIDS costs in Spain by simulation technics]F Antoñanzas Villar, F Antón Botella, C Juárez Castello
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 9, 2014
Some economics on personalized and predictive medicineF Antoñanzas, C A Juárez-Castelló, R Rodríguez-Ibeas
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 3, 2022
Does diagnostic testing always decrease antibiotics prescriptions?F Antoñanzas, C A Juárez-Castelló, R Rodríguez-Ibeas
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Gaceta Sanitaria|November 6, 2003
[Economic evaluation of pharmacotherapies for smoking cessation]F Antoñanzas, F Portillo
Gaceta Sanitaria|October 10, 2002
[Primary care: decentralization and efficiency]M Pinillos, F Antoñanzas
Revista Clinica Espanola|June 14, 2020
Assessment of the quality of antibiotics prescription in a regional health systemP Rojas García, F Antoñanzas Villar
Medicina Clinica|June 6, 1992
[A cost-effectiveness analysis of vaccination against the hepatitis B virus]F Antoñanzas, T Forcén, R Garuz
Revista Clinica Espanola|November 9, 2021
Assessment of the quality of antibiotics prescription in a regional health systemP Rojas García, F Antoñanzas Villar
Medicina Clinica|November 28, 1992
[Economic evaluation of prophylaxis with recombinant granulopoiesis stimulating factor]F Antoñanzas, J Rovira, R Garuz, et al.
Gaceta Sanitaria|December 3, 2002
[The cost of type 2 diabetes in Spain: the CODE-2 study]M Mata, F Antoñanzas, M Tafalla, et al.
Medicina Clinica|April 22, 1995
[The calculation of AIDS costs in Spain by simulation technics]F Antoñanzas Villar, F Antón Botella, C Juárez Castello
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 9, 2014
Some economics on personalized and predictive medicineF Antoñanzas, C A Juárez-Castelló, R Rodríguez-Ibeas
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 3, 2022
Does diagnostic testing always decrease antibiotics prescriptions?F Antoñanzas, C A Juárez-Castelló, R Rodríguez-Ibeas
Pageof 3